Meet Our Professionals >
How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>
Search our Experience
Envision to Sell to KKR for $9.9 Billion
We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more
Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.
Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.
Click here to download the guide.
Scott McLeod assists publicly-traded real estate investment trusts (REITs), commercial real estate developers, and private businesses navigate the complexities of commercial real estate transactions. With experience as both borrower's and lender's counsel, he assists on a broad range of financings. His practice involves:
Memphis Bar Association
Tennessee Bar Association
American Bar Association
Mid-South Super Lawyers "Rising Star" (2017)
Tennessee Law Review — Executive Editor
Transactions: the Tennessee Journal of Business Law — Third-Year Editor
Academic Excellence Awards — Commercial Leasing, Land Use Law, Intellectual Property
Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.